Subject: Huge MJNA News and CNAB Rebounds Up Yesterday and Holds Today

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
Huge MJNA News and CNAB Rebounds Up Yesterday and Holds Today
Hot Stock to WatchHot Stock to Watch

Company: Medical Marijuana Inc. (Pink Sheets: MJNA)

End of Day:

Price: 0.1212

Change (%): + 0.0001 (0.08)

Volume: 2,568,185
MJNA Chart

Photo Release -- Medical Marijuana, Inc. Signs Definitive Agreement to Acquire Kannaway, LLC

119.6-242.7 Million Dollar Valuation by Houlihan Capital, a Firm That Performed Similar Valuations for U.S. Airways, Inc. and Redbox

SAN DIEGO, Jan. 22, 2015 (GLOBE NEWSWIRE) - Medical Marijuana, Inc. (OTC Pink: MJNA), a leading industrial hemp industry innovator, is proud to announce that it has signed a definitive agreement to acquire 100% membership interest of Kannaway, LLC. The amount of the sale is undisclosed. The valuation of Kannaway is in the range of 119.6-242.7 million dollars. The agreement is expected to take at least 90 days to close and will effectively make the cannabis-based network marketing company a wholly owned subsidiary of the first-ever publicly traded cannabis company.

Kannaway’s valuation was performed by none other than esteemed financial advisory and investment banking firm, Houlihan Capital. The firm has performed valuations for similar category creators including: Urban Outfitters, Redbox, Micros Systems Inc., LeapFrog Enterprises, Tootsie Roll Enterprises, U.S. Airways Inc., and more. Houlihan Capital is a Financial Industry Regulatory Authority (FINRA) and SIPC member, committed to the highest levels of professional ethics and standards.

Continue Reading

Top PerformerYesterday's Top Performer

United Cannabis Corp. (OTCQB: CNAB)

End of Day:

Price: 1.47

Change (%): + 0.21 (16.67)

Volume: 78,907
CNAB Chart

About United Cannabis Corporation

United Cannabis Corporation was founded to advance the use of cannabinoids in medicine through research, product development and education. The Company is dedicated to improving the lives of patients through the creation of products using only the highest quality genetics, purest extractions and most effective protocols possible. The Company's A.C.T. Now Program and patent-pending Prana Bio Nutrient Medicinals provide a comprehensive solution, designed to enable physicians and patients to design, implement and monitor effective therapy protocols.

Company Information Sheet

Other Small Cap News

Company: Breitling Energy Corporation (OTCBB: BECC)

Breitling Energy Announces Second Newton County, Texas Prospect

DALLAS--(BUSINESS WIRE)--Breitling Energy Corporation (OTCBB: BECC) announces participation in a well that just completed drilling and logging, showing promise of production from the Yegua Sands in southeast Texas. The Seely Hankamer #1 was drilled to a vertical depth of 7,966 feet, with casing run and log reports evaluated.

As anticipated by extensive 3D seismic evaluation prior to spud, the well is showing potential production in two sections of the Yegua Sands, an area northeast of Port Arthur, which has consistently produced vertical oil wells for years. Initial log evaluation indicates the well’s production should be favorable compared to surrounding wells. Because of its proximity to distribution centers, transportation costs from Newton County to Gulf Coast refineries are negligible.

Continue Reading

Company: InVivo Therapeutics Holdings Corp. (OTCQB: NVIV)

InVivo Therapeutics Announces Enrollment of Second Subject in Pilot Spinal Cord Injury Trial

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today announced that a second subject has been enrolled in the pilot study of its Neuro-Spinal Scaffold for the treatment of complete traumatic spinal cord injury (SCI) at the Carolinas Medical Center, part of the Carolinas HealthCare System in Charlotte, NC. The objective of the pilot study is to evaluate the safety and feasibility of the Neuro-Spinal Scaffold as well as to gather preliminary evidence of effectiveness.

Dr. Domagoj Coric, Chief of Neurosurgery at Carolinas Medical Center, together with Dr. William Bockenek, Chief Medical Officer of Carolinas Rehabilitation, are Co-Principal Investigators at this site. Dr. Coric and his partner Dr. John Ziewacz, both of the Carolina Neurosurgery and Spine Associates, performed the second-ever Neuro-Spinal Scaffold implant into an acute spinal cord injury patient. Dr. Coric commented, “This subject sustained a severe, multi-trauma injury that required my team to wait two days for the subject to stabilize medically before proceeding with the concurrent spinal stabilization and implantation surgery. The implantation procedure was a success, and I look forward to monitoring the subject’s progress.”

Continue Reading

Market News

By Abigail Stevenson: CNBC

Cramer Remix: Hold this stock for the long term

Some ascribe Wednesday's market rally to the possibility that the European Central Bank will jumpstart Europe 's economy on Thursday. Others pinned it to Obama speech about soaking the rich on Tuesday evening. Not Jim Cramer. He said the rally was born on the back of one measly stock-Netflix (NFLX).

"Netflix is an odd bird, one of those stocks that people want to own because they love Netflix, the service. There's nothing the matter with that. I just find it hard to value, which is why I call it a cult stock," said the "Mad Money" host.

Cramer refers to what he calls "cult stocks" as those stocks that do not trade on revenues or earnings. They trade based on sexy press releases, or in Netflix's case, on new subscribers and new releases of Orange is the New Black" or "Marco Polo."

Continue Reading

By Paul Carrel:

ECB agrees landmark sovereign bond-buy plan

FRANKFURT (Reuters) - The European Central Bank agreed on Thursday to embark on a quantitative easing (QE) programme, which together with its existing schemes will pump 60 billion euros a month into the euro zone economy from this March until September next year.

Countries under a bailout programme, such as Greece, will be included but with some additional criteria.

The ECB is launching the programme with a view to buoying the flagging euro zone economy, where inflation has turned negative and - at minus 0.2 percent - is far below the central bank's target of just under 2 percent.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks